ストックスクリーナーアプリを入手
1.28
5.79%
0.07
アフターアワーズ：
1.21
-0.07
-5.47%
前日終値:
$1.21
開ける：
$1.2
24時間の取引高:
146.82K
Relative Volume:
0.46
時価総額：
$14.20M
収益：
$28.51M
当期純損益:
$-26.40M
株価収益率:
-0.2338
EPS:
-5.4756
ネットキャッシュフロー:
$-16.35M
1週間 パフォーマンス:
+8.47%
1か月 パフォーマンス:
+15.32%
6か月 パフォーマンス:
-39.48%
1年 パフォーマンス:
-71.36%
1日の値動き範囲:
$1.20
$1.28
1週間の範囲:
$1.1201
$1.28
52週間の値動き範囲:
$1.06
$5.50
Bionano Genomics Inc Stock (BNGO) Company Profile
名前
Bionano Genomics Inc
セクター
電話
(858) 888-7600
住所
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.28 | 13.42M | 28.51M | -26.40M | -16.35M | -5.4756 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-15 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-12-12 | 再開されました | BTIG Research | Buy |
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
| 2021-06-16 | 開始されました | BTIG Research | Buy |
| 2020-09-24 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-04-08 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Bionano Genomics Inc (BNGO) 最新ニュース
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN
H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $6 - Moomoo
BNGO Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Take Profit: Is Bionano Genomics Inc benefiting from interest rate changesWeekly Investment Report & Community Driven Trade Alerts - baoquankhu1.vn
Keys to Succeed in the Booming $300 Million Optical Genome - GlobeNewswire
Breakout Zone: What is Bionano Genomics Incs P E ratio telling us2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Aug Update: Is Bionano Genomics Inc part of any ETFQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Bionano Genomics stock price target lowered to $6 by H.C. Wainwright - Investing.com
Weekly Recap: Is Bionano Genomics Inc stock a value trap2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO) - The Globe and Mail
Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance Singapore
BNGO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bionano Genomics, Inc. (BNGO) Stock Price, News, Quote & History - Yahoo! Finance Canada
[ARS] Bionano Genomics, Inc. SEC Filing - Stock Titan
Bionano Genomics (NASDAQ: BNGO) outlines 2026 virtual meeting and proxy votes - Stock Titan
Aug Highlights: Is Bionano Genomics Inc benefiting from interest rate changes2026 Buyback Activity & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - Bitget
In 211 myeloma samples, OGM found abnormalities older tests missed - Stock Titan
Q4 2024 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Volume Summary: Is Bionano Genomics Inc backed by strong institutional buying2026 PostEarnings & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Profit Review: Is Bionano Genomics Inc part of any ETFWeekly Trade Recap & High Accuracy Buy Signal Tips - baoquankhu1.vn
Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion - MSN
Bionano Genomics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-03-24 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript - Insider Monkey
Bionano Genomics Reports 2025 Financial Results, Highlights OGM Adoption and Announces 2026 Revenue Outlook - minichart.com.sg
Bionano Genomics 2025 Annual Report Highlights: Optical Genome Mapping, Market Expansion, and Risk Factors 57596054 - Minichart
Bionano Q4 2025 slides: margins surge 47% as cost cuts offset revenue dip - Investing.com Canada
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Earnings Call Summary | Bionano Genomics(BNGO.US) Q4 2025 Earnings Conference - Moomoo
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Q4 2025 slides: margins surge 47% as cost cuts offset revenue dip By Investing.com - Investing.com South Africa
Bionano Genomics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bionano Genomics (BNGO) Reports Q4 2025 Earnings, Sets 2026 Reve - GuruFocus
Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Bionano Genomics (BNGO) Earnings Transcript - AOL.com
Earnings call transcript: Bionano Genomics’ Q4 2025 results show cost cuts, stock surges By Investing.com - Investing.com South Africa
Bionano Genomics (BNGO) Sees Promising Growth in Optical Genome Mapping - gurufocus.com
Earnings call transcript: Bionano Genomics’ Q4 2025 results show cost cuts, stock surges - Investing.com
Bionano Genomics (BNGO) Reports Q4 Revenue Beat Despite Lower Sa - GuruFocus
Bionano Genomics Inc (BNGO) DEC/2025 Earning Prediction - Intellectia AI
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story - Benzinga
BNGO Projects Revenue Growth for FY26 - GuruFocus
Bionano Genomics shares are trading higher af... - benzinga.com
Bionano Genomics 2025 10-K: Revenue $28.5M, EPS $(4.85) - TradingView
Bionano Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Going-concern risk and OGM growth focus at Bionano Genomics (NASDAQ: BNGO) - Stock Titan
Bionano Genomics Sees FY2026 Sales $30.000M-$33.000M vs $35.075M EstBionano Genomics (NASDAQ:BNGO) - benzinga.com
Bionano Genomics Inc (BNGO) 財務データ
収益
当期純利益
現金流量
EPS
0.06%
1.84%
大文字化:
|
ボリューム (24 時間):